evaluate the pharmaceuticals company zepbound on glp-1 efficacy / effectiveness Lilly is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating Emerging Frontiers in GLP-1 Therapeutics:

In the ORIGIN trial, the overall incidence of cancer (all types combined) (Hazard Ratio [95% CI]

Cost is a concern since it affects demand in a few markets

N Engl J Med 333(9):550554

Weight loss drugs are expensive and are covered by some insurance plans, but most people get insurance through their employers, so its a question of whether employers opted in or out of weight loss benefits, says Michelle Pearlman, MD, CEO and co-founder of Prime Institute and ByteMD and a physician who is board-certified in internal medicine, gastroenterology, and obesity medicine

3 The receptor expression in this brain structure nullifies the neurotransmitter -aminobutyric acid (GABA) transmission, hence decreasing the motivation to seek alcohol in those with AUD

The pancreas and liver make more insulin when they need to and less glucagon when they don't